We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Diabetes

Journal Scan / Research · November 23, 2020

Comparison of Clinical, Equivalent Doses of Insulin Glargine and Insulin Degludec in T1D

Diabetes Care


Additional Info

Diabetes Care
Pharmacokinetic and Pharmacodynamic Head-to-Head Comparison of Clinical, Equivalent Doses of Insulin Glargine 300 Units/mL and Insulin Degludec 100 Units/mL in Type 1 Diabetes
Diabetes Care 2020 Nov 01;[EPub Ahead of Print], P Lucidi, P Candeloro, P Cioli, A Marinelli Andreoli, C Pascucci, A Gambelunghe, GB Bolli, CG Fanelli, F Porcellati

Further Reading